Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling Pathways
article
OA: green
CC0
⤵ 60 in-corpus citations
AI-generated summary
Macrophage migration inhibitory factor up-regulates cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells via p38 and ERK MAPK pathways.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Cyclooxygenase (COX) is the rate-limiting enzyme in the metabolic conversion of arachidonic acid to prostaglandins (PGs), including prostaglandin E(2) (PGE(2)), a major mediator of inflammation and angiogenesis. Herein, we report that macrophage migration inhibitory factor (MIF), a potent proinflammatory and growth-promoting factor found at elevated concentrations in the peritoneal fluid of women with endometriosis and active endometriosis lesions, acts directly on ectopic endometrial cells to stimulate the synthesis of COX-2, the inducible form of COX, and the release of PGE(2). MIF treatment strongly activated p38 and ERK MAPK, and specific inhibitors of both pathways completely blocked basal and MIF-induced PGE(2) synthesis. Whereas p38 inhibitors negatively affected the stimulated synthesis of COX-2 and that of PGE(2), ERK inhibitors only decreased the production of PGE(2). These findings show for the first time a direct role for MIF in the up-regulation of COX-2 synthesis and PGE(2) secretion in ectopic endometrial cells. They further indicate that whereas p38 and ERK MAPK signaling pathways both play a significant role in the regulation of basal and MIF-induced synthesis of PGE(2) by ectopic endometrial cells, only p38 kinase is involved in the regulation of COX-2 expression in these cells. This suggests that MIF acts at more than one level to stimulate the synthesis of PGE(2) and triggers the coordinate activation of multiple enzymes in the biosynthesis pathway. Our data provide evidence for a novel mechanism by which MIF can induce a proinflammatory phenotype in ectopic endometrial cells, and favor the establishment of endometriosis and its related clinical symptoms.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (80)
- Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises via openalex
- Aromatase and other steroidogenic genes in endometriosis: translational aspects via openalex
- Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture via openalex
- Cytolysis of Eutopic and Ectopic Endometrial Cells by Peripheral Blood Monocytes and Peritoneal Macrophages in Women with Endometriosis via openalex
- Direct effect of macrophage migration inhibitory factor on sperm function: possible involvement in endometriosis-associated infertility via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Endometriosis via openalex
- Endometriosis and angiogenesis. via openalex
- Extracellularly Signal-Regulated Kinase Activity in the Human Endometrium: Possible Roles in the Pathogenesis of Endometriosis via openalex
- Immunology of endometriosis via openalex
- Immunology of endometriosis. via openalex
- Is Endometriosis Associated with Systemic Subclinical Inflammation? via openalex
- Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis via openalex
- Paracrine regulation of endometriotic tissue via openalex
- Possible Pathophysiological Roles of Mitogen‐Activated Protein Kinases (MAPKs) in Endometriosis via openalex
- Prostaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells via openalex
- Prostaglandin E<sub>2</sub>Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells<sup>1</sup> via openalex
- The peritoneal environment in endometriosis via openalex
- The staging of peritoneal endometriosis by the type of active lesion in addition to the revised American Fertility Society classification via openalex
- W2060242196 via openalex
- W2067652148 via openalex
- W2068716048 via openalex
- W2071890540 via openalex
- W2072607751 via openalex
- W2074840148 via openalex
- W2078445513 via openalex
- W2082457469 via openalex
- W2083491682 via openalex
- W2084015052 via openalex
- W2085052924 via openalex
- W2087968772 via openalex
- W2091307965 via openalex
- W2094369576 via openalex
- W2099965878 via openalex
- W2104956743 via openalex
- W2109606512 via openalex
- W2109643289 via openalex
- W2110705119 via openalex
- W2111199059 via openalex
- W2117021879 via openalex
- W2121697121 via openalex
- W2121737682 via openalex
- W2127564444 via openalex
- W2130463115 via openalex
- W2131581428 via openalex
- W2133633020 via openalex
- W2145218740 via openalex
- W2145385694 via openalex
- W2154581760 via openalex
- W2155225555 via openalex
- W2155438634 via openalex
- W2161048718 via openalex
- W2342153330 via openalex
- W4211081176 via openalex
- W4250694871 via openalex
- W6601830869 via openalex
- W6678183996 via openalex
- W6713381459 via openalex
- W6814680148 via openalex
- W6832349645 via openalex
- W46942126 via openalex
- W1850638409 via openalex
- W1972096011 via openalex
- W1974981405 via openalex
- W1986132916 via openalex
- W1989832114 via openalex
- W1990030459 via openalex
- W1999191094 via openalex
- W2002354023 via openalex
- W2013079253 via openalex
- W2033465412 via openalex
- W2035171028 via openalex
- W2041327426 via openalex
- W2044204905 via openalex
- W2049619918 via openalex
- W2051419956 via openalex
- W2055851568 via openalex
- W2056145429 via openalex
- W2057685998 via openalex
Cited by (50)
- The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets 2026
- Balancing Decidualization, Autophagy, and Cellular Senescence for Reproductive Success in Endometriosis Biology 2025
- The long road of drug development for endometriosis – Pains, gains, and hopes 2024
- Immune pathway through endometriosis to ovarian cancer 2024
- Causal association of immune cells and endometriosis: a Mendelian randomization study 2024
- Research advances in endometriosis-related signaling pathways: A review 2023
- Adenomyosis as a Risk Factor for Myometrial or Endometrial Neoplasms—Review 2022
- Dissecting the miR-451a-Mif Pathway in Endometriosis Pathophysiology Using a Syngeneic Mouse Model: Temporal Expression of Lesion Mif Receptors, Cd74 and Cxcr4 2022
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
- Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies† 2021
- Zinc(II) niflumato complex effects on MMP activity and gene expression in human endometrial cell lines 2021
- The Relationship between Functional Promoter Variants of Macrophage Migration Inhibitory Factor and Endometriosis. 2021
- Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review 2021
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling 2021
- Serum macrophage migration inhibition factor for diagnosing endometriosis and its severity: case-control study 2020
- Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPk Activation in Endometriosis 2019
- Is Long-Term Dienogest Treatment Tolerable in Korea? 2019
- Proteomics Research and Its Possibility of Application in Endometriosis 2019
- Comparing The Effects of Glycyrrhiza glabra Root Extract, A Cyclooxygenase-2 Inhibitor (Celecoxib) and A Gonadotropin-Releasing Hormone Analog (Diphereline) in A Rat Model of Endometriosis. 2019
- Systematic analysis of hsa-miR-363 gene overexpression pattern in endometrial stromal cells 2018
- Basic mechanisms of vascularization in endometriosis and their clinical implications 2018
- Macrophage Migration Inhibitory Factor Receptor, CD74, is Overexpressed in Human and Baboon (Papio Anubis) Endometriotic Lesions and Modulates Endometriotic Epithelial Cell Survival and Interleukin 8 Expression 2018
- PTGFR activation promotes the expression of PTGS-2 and growth factors via activation of the PKC signaling pathway in bovine endometrial epithelial cells 2018
- Endometriosis — insights into a multifaceted entity 2018
- Curcumin attenuates proangiogenic and proinflammatory factors in human eutopic endometrial stromal cells through the NF‐κB signaling pathway 2018
- Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics 2016
- Augmented Angiogenic Factors Expression via FP Signaling Pathways in Peritoneal Endometriosis 2016
- Macrophages promote the growth and invasion of endometrial stromal cells by downregulating IL-24 in endometriosis 2016
- Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment 2016
- Molecular Biology of Endometriosis 2016
- MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis? 2015
- Role of Macrophage Migration Inhibitor Factor in Endometriosis 2015
- The expression of microRNA-451 in human endometriotic lesions is inversely related to that of macrophage migration inhibitory factor (MIF) and regulates MIF expression and modulation of epithelial cell survival 2015
- Endometriosis and possible inflammation markers 2015
- Abnormal Expression of Prostaglandins E2 and F2<i>α</i>Receptors and Transporters in Patients with Endometriosis 2015
- Roles of Prostaglandin E2 in Endometriosis 2014
- Suppression of COUP-TFII by Proinflammatory Cytokines Contributes to the Pathogenesis of Endometriosis 2014
- Macrophage migration inhibitory factor as a potential biomarker of endometriosis 2014
- Macrophage Migration Inhibitory Factor Is Involved in Ectopic Endometrial Tissue Growth and Peritoneal-Endometrial Tissue Interaction In Vivo: A Plausible Link to Endometriosis Development 2014
- Macrophages in Pathophysiology of Endometriosis 2014
- Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis 2013
- Pathogenesis of endometriosis: The role of initial infection and subsequent sterile inflammation (Review) 2013
- Suppression of annexin A2 by prostaglandin E2 impairs phagocytic ability of peritoneal macrophages in women with endometriosis 2013
- Endometriosis, Leiomyoma and Adenomyosis: the Risk of Gynecologic Malignancy 2013
- Ovarian cancers arising from endometriosis: A microenvironmental biomarker study including ER, HNF1ß, p53, PTEN, BAF250a, and COX-2 2013
- Possible effects of endometriosis-related immune events on reproductive function 2013
- Regression of Experimentally Induced Endometriosis with a New Selective Cyclooxygenase-2 Enzyme Inhibitor 2013
- Hypoxia-Induced MicroRNA-20a Expression Increases ERK Phosphorylation and Angiogenic Gene Expression in Endometriotic Stromal Cells 2012
- Involvement of Prostaglandins in the Pathophysiology of Endometriosis 2012
- Macrophage Migration Inhibitory Factor Antagonist Blocks the Development of Endometriosis In Vivo 2012
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:14:11.755070+00:00
License: CC0
· commercial use OK